Structural Biology of Polyether Antibiotic Biosynthesis
Structural Biology of Polyether Antibiotic Biosynthesis
批准号:
10261453
负责人:
Chu-Young Kim
金额:
$15.1万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-09-15 至 2025-08-31
关键词:
Acyl Carrier ProteinAcyltransferaseAnabolismAnti-Bacterial AgentsAntibioticsAntifungal AgentsBacteriaBiochemicalBiogenesisBiological ModelsChemicalsComplexCrystallizationCyclic EthersCyclizationDevelopmentDockingEngineeringEnsureEnzymesEpoxide hydrolaseEpoxy CompoundsFamilyFlavinsFoundationsFutureGene ClusterGoalsInvestigationLaboratoriesMixed Function OxygenasesMolecularMolecular ConformationNatural ProductsNatureOrganismPathway interactionsPharmaceutical ChemistryPharmaceutical PreparationsPolyenesProductionPropertyReactionResearchSchemeSolidStreptomycesStructureSubgroupTechniquesTestingTherapeuticTimeVertebral columnWorkYeastsanti-cancerbasedimerdrug developmentenzyme biosynthesisnovelnovel therapeuticspolyketide synthaseprogramsprotein protein interactionsealstructural biology
中文摘要
我们研究计划的首要目标是阐明自然界如何产生聚醚
天然产品。聚醚是聚酮化合物天然产物的一个亚组,作为一类,它们
具有广泛的有用活性,包括抗细菌、抗真菌和抗癌
特性.然而,聚醚药物的开发受到我们无法快速和
高效合成天然聚醚及其衍生物用于药物化学和药物
优化研究这是由于天然聚醚的结构异常复杂。一个
该问题的有吸引力的解决方案是使用工程化的生物合成复合聚醚,
实验室友好的有机体,如细菌或酵母。预计这一做法将使
无数新的聚醚可用于药物研究。为了创建一个强大而可靠的
聚醚生物生产平台,首先要实现详细全面的
了解聚醚是如何在生物体中产生的。100多种不同
迄今为止,已经发现了聚醚天然产物,
生物合成基因簇表明,所有聚醚都是通过一个共同的三个阶段产生的,
生物合成方案阶段1:通过模块化聚酮化合物构建聚酮化合物主链
- 是的阶段2:通过单加氧酶对多烯中间体进行立体选择性环氧化。
阶段3:通过一种或多种环氧化物水解酶形成标志性环醚基团。的
该方案的普遍性确保了对任何一种特定聚醚的研究
生物合成途径及其相关的酶将导致对如何
大自然产生聚醚。在这个项目中,我们将研究来自
拉沙洛西A来自拉萨利链霉菌的生物合成途径。拉沙洛西A生物合成
pathway是研究自然界如何产生聚醚的极好模型系统,因为它
由九种酶组成,但它拥有所有标志性的化学转化,
聚醚生物合成
英文摘要
The overarching goal of our research program is to elucidate how nature produces polyether
natural products. Polyethers are a subgroup of polyketide natural products and, as a class, they
possess a wide range of useful activities, including antibacterial, antifungal, and anticancer
properties. However, polyether drug development is hampered by our inability to quickly and
efficiently synthesize natural polyethers and their derivatives for medicinal chemistry and drug
optimization studies. This is due to the unusually complex structure of natural polyethers. An
attractive solution to this problem is to biosynthesize complex polyethers using engineered
laboratory-friendly organisms such as bacteria or yeast. This approach is expected to make
countless new polyethers accessible for drug research. In order to create a robust and reliable
polyether bioproduction platform, we must first achieve a detailed and comprehensive
understanding of how polyethers are produced in living organisms. More than 100 different
polyether natural products have been discovered so far, and examination of known polyether
biosynthetic gene clusters show that all polyethers are generated via a common three-stage
biosynthetic scheme. Stage 1: construction of the polyketide backbone by modular polyketide
synthases. Stage 2: stereoselective epoxidation of the polyene intermediate by a monooxygenase.
Stage 3: formation of the hallmark cyclic ether groups by one or more epoxide hydrolases. The
universal nature of this scheme ensures that investigation of any one particular polyether
biosynthesis pathway and its associated enzymes will lead to a general understanding of how
nature generates polyethers. In this project, we will study the biosynthetic enzymes from the
lasalocid A biosynthesis pathway from Streptomyces lasaliensis. Lasalocid A biosynthesis
pathway is an excellent model system for studying how nature produces polyethers because it
consists of just nine enzymes, yet it possesses all the hallmark chemical transformations of
polyether biosynthesis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Structural biology of polyether antibiotic biosynthesis
-
批准号:10912964
-
项目类别:
-
资助金额:$31.72万
-
财政年份:2020
-
负责人:Chu-Young Kim
-
依托单位:
Selective targeting of human alkaline phosphatase isozymes
-
批准号:10359823
-
项目类别:
-
资助金额:$15.1万
-
财政年份:2020
-
负责人:Chu-Young Kim
-
依托单位:
Selective targeting of human alkaline phosphatase isozymes
-
批准号:10117265
-
项目类别:
-
资助金额:$15.1万
-
财政年份:2020
-
负责人:Chu-Young Kim
-
依托单位:
Structural Biology of Polyether Antibiotic Biosynthesis
-
批准号:10036330
-
项目类别:
-
资助金额:$15.1万
-
财政年份:2020
-
负责人:Chu-Young Kim
-
依托单位:
海外基金